Skip to main content

Table 3 Interaction between sleeping characteristics and the factors in association with NAFLD using likelihood ratio test

From: Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study

Sleep characteristics

Modifier

N

N events

RR

95% CI

p-interaction a

Sleep duration

Male

-

-

0.97

0.92–1.03

0.78

Female

-

-

0.98

0.94–1.03

Age ≤ 40

-

-

0.99

0.89–1.10

0.25

Age 40–60

-

-

0.99

0.95–1.03

Age ≥ 60

-

-

0.92

0.84–1.00

BMI ≤ 25

-

-

0.91

0.83–1.00

0.17

BMI 25–30

-

-

0.96

0.89–1.02

BMI ≥ 30

-

-

1.01

0.95–1.08

Wake up time category (hour) (≤ 6 a.m.)

Male

-

-

0.85

0.71–1.01

0.20

Female

-

-

0.98

0.86–1.11

Age ≤ 40

-

-

0.94

0.69–1.29

0.23

Age 40–60

-

-

0.97

0.86–1.09

Age ≥ 60

-

-

0.75

0.58–0.98

BMI ≤ 25

-

-

1.08

0.78–1.48

0.62

BMI 25–30

-

-

0.93

0.80–1.08

BMI ≥ 30

-

-

0.90

0.78–1.05

Bed time category (hour) (≤ 10 p.m.)

Male

-

-

0.73

0.58–0.93

0.03

Female

-

-

0.99

0.85–1.15

Age ≤ 40

-

-

1.27

0.88–1.83

0.02

Age 40–60

-

-

0.93

0.80–1.09

Age ≥ 60

-

-

0.66

0.49–0.90

BMI ≤ 25

-

-

0.75

0.50–1.11

0.59

BMI 25–30

-

-

0.92

0.75–1.12

BMI ≥ 30

-

-

0.92

0.77–1.12

Sleep efficiency

Male

-

-

0.89

0.83–0.96

0.26

Female

-

-

0.94

0.89–0.99

Age ≤ 40

-

-

1.01

0.97–1.04

 < 0.001

Age 40–60

-

-

0.87

0.82–0.94

Age ≥ 60

-

-

0.81

0.70–0.93

BMI ≤ 25

-

-

1.01

0.98–1.04

0.01

BMI 25–30

-

-

0.92

0.86–0.99

BMI ≥ 30

-

-

0.89

0.84–0.94

Day time nap (yes)

Male

2622

470

1.27

1.05–1.53

0.007

Female

2380

326

0.94

0.83–1.06

Age ≤ 40

910

104

1.06

0.79–1.42

0.87

Age 40–60

3369

579

1.02

0.90–1.15

Age ≥ 60

723

113

1.10

0.84–1.43

BMI ≤ 25

1290

85

1.24

0.90–1.71

 < 0.001

BMI 25–30

2297

396

1.29

1.10–1.52

BMI ≥ 30

1413

315

0.81

0.70–0.94

Restless legs syndrome

Male

652

142

0.96

0.74–1.25

0.29

Female

459

53

0.81

0.69–0.95

Age ≤ 40

162

16

1.02

0.62–1.68

0.71

Age 40–60

770

150

0.83

0.71–0.97

Age ≥ 60

179

29

0.87

0.61–0.94

BMI ≤ 25

282

15

1.11

0.65–1.90

0.53

BMI 25–30

490

89

0.81

0.66–0.99

BMI ≥ 30

339

91

0.85

0.70–1.03

Use of sleeping pills

Male

340

93

1.52

0.95–2.43

0.60

Female

151

24

1.75

1.35–2.29

Age ≤ 40

53

9

1.74

0.81–3.76

0.98

Age 40–60

237

83

1.71

1.30–2.25

Age ≥ 60

111

25

1.63

0.99–2.69

BMI ≤ 25

124

11

1.43

0.73–2.81

0.86

BMI 25–30

212

50

1.72

1.23–2.42

BMI ≥ 30

155

56

1.75

1.23–2.49

  1. Abbreviations: Risk Ratios and 95% confidence intervals (RR [95% CI]) for estimation using log-binomial regression
  2. a Interaction analyses were assessed using Model2 + BMI
  3. Note: N and N events are not applicable for continuous variables